Clinical trial NCT07369804 investigates the safety and efficacy of focused LED-based red-light therapy in myopic adults. The Hong Kong Polytechnic University sponsors this study.
As of 2026-01-27T14:06:55.000Z, the study is recruiting participants.
In this article: What is red-light therapy? | Study details | FAQ | Conclusion | Disclaimer | Announcement line
What is red-light therapy?
Red-light therapy, also known as low-level laser therapy or photobiomodulation, is a non-invasive treatment that uses red or near-infrared light to stimulate cellular processes.
How does it work?
The exact mechanisms of red-light therapy are not fully understood, but it is thought to increase energy production in cells, reduce inflammation, and promote tissue repair.
Study details
The study aims to investigate the safety and efficacy of focused LED-based red-light therapy in myopic adults. The device used in the study is a fLED-based red-light therapy device.
Who is eligible to participate?
Myopic adults are eligible to participate in the study.
What are the potential benefits and risks?
The potential benefits of the study include improved vision and reduced myopia progression. The potential risks include eye discomfort and headaches.
FAQ
- What is the purpose of the study?
The purpose of the study is to investigate the safety and efficacy of focused LED-based red-light therapy in myopic adults.
- Who is sponsoring the study?
The Hong Kong Polytechnic University is sponsoring the study.
- How can I participate in the study?
To participate in the study, you must be a myopic adult and meet the eligibility criteria.
Conclusion
The study on focused LED-based red-light therapy for myopic adults is a breakthrough in the field of ophthalmology. The results of the study will provide valuable insights into the safety and efficacy of this non-invasive treatment.
Disclaimer
This article is not intended to provide medical advice. The information contained in this article is for general information purposes only.